A joint MRC/European Organisation for Research and Treatment of Cancer (EORTC) study of radiotherapy for low grade astrocytomas and oligodendrogliomas

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17931175

Enrollment

250

Registered

2001-02-28

Start date

1986-08-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Astrocytomas and oligodendrogliomas

Interventions

Two groups - post-operative radiotherapy and no post-operative radiotherapy.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 16-66 2. World Health Organisation (WHO) performance status 0-2 3. Neurosurgery within past 8 weeks 4. No previous malignancy 5. No previous treatment except surgery 6. Corticosteroids, anticonvulsants or diuretics 7. No condition likely to prejudice treatment or follow up

Exclusion criteria

Exclusion criteria: History of cardiac disease

Design outcomes

Primary

Measure	Time frame
Survival time, Morbidity, Time to progression	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026